Answers are grounded in this paper and cite their sources.
Advances in surgery and chemotherapy regimens have increased the long-term survival of patients with colorectal liver metastases (CRLM). Although liver resection remains an essential part of any curative strategy for resectable CRLM, chemotherapy regimens have also improved the long-term outcomes. However, the optimal timing for chemotherapy regimens remains unclear. Thus, this review addressed key points to aid the decision-making process regarding the timing of chemotherapy and surgery for patients with resectable CRLM. J. Surg. Oncol. 2017;115:213-220.
No takes yet. Share an insight, caveat, or question.
Araújo et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: